Two Hemophilia Treatments Among 15 New EU Filings

EU marketing authorization applications for a number of new medicines have started the regulatory review process.

gene therapy
The EMA is reviewing a marketing application for a new gene therapy for hemophilia B • Source: Shutterstock

More from Europe

More from Geography